Table 1.
Baseline characteristics of patients with mid-portion Achilles tendinopathy according to allocation to autologous blood injections (treatment) or dry needling (control). Figures are numbers (percentage) of participants unless stated otherwise
| Characteristics | Treatment (n=26) | Control (n=27) |
|---|---|---|
| Mean (SD) age (years) | 51.2 (10.6) | 47.2 (9.7) |
| Men | 16 (62) | 12 (44) |
| European | 24 (92) | 24 (89) |
| Left side affected | 20 (77) | 13 (48) |
| Mean (SD) duration of symptoms (months) | 22.9 (33.1) | 38.6 (84.6) |
| Mean (SD) duration of symptoms (months) (in those with duration ≤100 months) | 14.8 (17.4) | 17.7 (20.1) |
| Participates in physical activity/sport | 22 (85) | 27 (100) |
| Physical activity: | ||
| No change | 12 (46) | 9 (33) |
| Reduced | 9 (35) | 7 (26) |
| Ceased | 5 (19) | 11 (41) |
| Changes on ultrasonography: | ||
| Severe | 5 (19) | 1 (4) |
| Moderate | 16 (62) | 17 (63) |
| Mild | 5 (19) | 9 (33) |
| Mean (SD) VISA-A score | 58.1 (SD 17.2) | 57.3 (SD 12.7) |